GREGORY GUNYAN: Open Payments
NPI 1528386265 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 23 payments from 5 companies in 2025. Trend: 2023 $838 · 2024 $936 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $327 |
| Axsome Therapeutics, Inc. | 8 | $217 |
| E.R. Squibb & Sons, L.L.C. | 4 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: Auvelity, ARISTADA, COBENFY, LYBALVI, CAPLYTA, INGREZZA.
Industry payments across NY — which companies pay providers there.
